{"id":2626,"date":"2025-02-26T10:26:21","date_gmt":"2025-02-26T10:26:21","guid":{"rendered":"https:\/\/genosophy.gr\/product\/ginetikos-elegxos-gia-diaviti-kuisis-kai-elegxos-thromvoseon\/"},"modified":"2025-04-24T14:48:08","modified_gmt":"2025-04-24T14:48:08","slug":"ginetikos-elegxos-gia-diaviti-kuisis-kai-elegxos-thromvoseon","status":"publish","type":"product","link":"https:\/\/genosophy.gr\/en\/product\/ginetikos-elegxos-gia-diaviti-kuisis-kai-elegxos-thromvoseon\/","title":{"rendered":"Genetic Test for Gestational Diabetes and Thrombosis Risk"},"content":{"rendered":"<p>The genetic test for gestational diabetes and thrombosis risk identifies genetic predispositions that may impact maternal and fetal health during pregnancy. Early detection through genetic testing enables timely intervention and preventive strategies, reducing potential complications.<\/p>\n<p><strong>Gestational diabetes<\/strong> is characterized by elevated blood sugar levels during pregnancy. Although it typically resolves after childbirth, it can lead to complications such as hypertension, premature birth, or increased fetal weight.<\/p>\n<p><strong>Thrombophilia<\/strong> is a genetic or acquired condition that increases the risk of blood clots, potentially causing severe pregnancy complications, including pulmonary embolism, hypercoagulability, or miscarriages. Testing for thrombophilia is particularly critical for women with recurrent miscarriages or a family history of blood-clot-related issues.<\/p>\n<p>&nbsp;<\/p>\n<h3>How Does Genetic Testing Help?<\/h3>\n<p>The test analyzes <strong>50 genetic loci<\/strong>, using an advanced algorithm to calculate the genetic risk for gestational diabetes. This analysis identifies women with twice the risk of developing gestational diabetes compared to women at low genetic risk.<\/p>\n<p>Additionally, the test includes <strong>11 variants<\/strong> related to thrombosis risk (Factor II, FV Leiden, FXIII, \u03b2-Fibrinogen, HPA1, MTHFR, ACE, APOB, APOE), enhancing the prediction of thromboembolic events. Results guide preventive treatments such as the use of low-molecular-weight heparin during pregnancy.<\/p>\n<p>&nbsp;<\/p>\n<h3>Genes Analyzed<\/h3>\n<ul>\n<li><strong>Gestational Diabetes:<\/strong>\n<ul>\n<li>Analysis of <strong>50 genetic variants<\/strong> associated with glucose metabolism and insulin resistance.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Thrombosis Risk:<\/strong>\n<ul>\n<li><strong>Factor II (Prothrombin)<\/strong><\/li>\n<li><strong>Factor V Leiden<\/strong><\/li>\n<li><strong>Factor XIII<\/strong><\/li>\n<li><strong>\u03b2-Fibrinogen<\/strong><\/li>\n<li><strong>HPA1<\/strong><\/li>\n<li><strong>MTHFR (Methylenetetrahydrofolate Reductase)<\/strong><\/li>\n<li><strong>ACE (Angiotensin-Converting Enzyme)<\/strong><\/li>\n<li><strong>APOB (Apolipoprotein B)<\/strong><\/li>\n<li><strong>APOE (Apolipoprotein E)<\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>Benefits of Genetic Testing<\/h3>\n<ul>\n<li><strong>Early Risk Assessment:<\/strong><br \/>\nAllows assessment of gestational diabetes risk even before pregnancy, enabling preventive measures.<\/li>\n<li><strong>Personalized Management:<\/strong><br \/>\nWomen identified as high genetic risk receive tailored dietary and lifestyle recommendations, significantly reducing their disease risk.<\/li>\n<li><strong>Preventive Treatments:<\/strong><br \/>\nIdentification of thrombophilia guides personalized preventive measures, potentially using anticoagulants to minimize the risk of complications.<\/li>\n<li><strong>Reduced Complications:<\/strong><br \/>\nEarly interventions can lower the incidence of hypertension, preeclampsia, miscarriage, or excessive fetal growth.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>Why Choose Genetic Testing?<\/h3>\n<p>Genetic testing provides precise risk evaluation, enabling proactive and personalized healthcare management during pregnancy. By identifying individuals at high genetic risk, targeted interventions can effectively reduce the risk of serious pregnancy complications, safeguarding the health of both mother and baby.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The genetic test for gestational diabetes and thrombosis risk identifies genetic predispositions that may impact maternal and fetal health during pregnancy. Early detection through genetic testing enables timely intervention and preventive strategies, reducing potential complications. Gestational diabetes is characterized by elevated blood sugar levels during pregnancy. Although it typically resolves after childbirth, it can lead [&hellip;]<\/p>\n","protected":false},"featured_media":2463,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[80],"product_tag":[],"class_list":{"0":"post-2626","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-metabolic-en","8":"first","9":"instock","10":"taxable","11":"shipping-taxable","12":"purchasable","13":"product-type-simple"},"acf":[],"_links":{"self":[{"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/product\/2626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/media\/2463"}],"wp:attachment":[{"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/media?parent=2626"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/product_brand?post=2626"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/product_cat?post=2626"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/genosophy.gr\/en\/wp-json\/wp\/v2\/product_tag?post=2626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}